Skip to content

JWP GmbH Drug Eluting Solutions

Plug and Play · JWP Drug Elution Solutions develops "in-bone micro-pharmacies" to transform orthopedic surgery by simultaneously controlling infection and actively regenerating bone, turning two-stage operations into one-stage.

Competitors

Adjacent

Also from Plug and Play

All of Plug and Play

Programs

Programs JWP GmbH Drug Eluting Solutions went through
ProgramCohortSource
Plug and PlayNot statedPlug and Play Page

About JWP GmbH Drug Eluting Solutions

JWP GmbH Drug Eluting Solutions is a MedTech company developing innovative "in-bone micro-pharmacies" designed to transform orthopedic surgery. Their technology enables simultaneous infection control and active bone regeneration, aiming to replace traditional two-stage operations with a single, more effective procedure. The company’s key products, OsteoFlux™ and OsteoSyn™, are engineered to deliver dual-action therapeutic effects that meet established clinical performance standards. Collaborations with leading nanomedicine experts and prominent medical institutions support the development and validation of these solutions. By integrating advanced drug-eluting technologies into orthopedic treatments, JWP GmbH is pioneering a novel approach that has the potential to significantly improve patient outcomes and streamline surgical processes in bone infection and fracture management.

Category
Other
Location
Germany
Checked
2h ago

JWP GmbH Drug Eluting Solutions: questions

Which accelerators did JWP GmbH Drug Eluting Solutions go through?

JWP GmbH Drug Eluting Solutions is listed by Plug and Play.

Where is JWP GmbH Drug Eluting Solutions based?

JWP GmbH Drug Eluting Solutions lists Germany as its location on Plug and Play's page.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.